Download - Eyeforpharma 2017
![Page 1: Eyeforpharma 2017](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58ed3f981a28ab1c768b460f/html5/thumbnails/1.jpg)
Making Access HappenRichard Francis, Division Head and CEO, SandozMarch 2017
Sandoz
![Page 2: Eyeforpharma 2017](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58ed3f981a28ab1c768b460f/html5/thumbnails/2.jpg)
Sandoz International
Sustainable universal access is a key global healthcare objective
>400m >2 billion
~2 million# of people who lack access to essential health services # of people who cannot access the medicines they need
# of preventable deaths every year due to tuberculosis and malaria
7.35 trillionGlobal cost of healthcare (2013):
Almost double the amount spent in 2000
Source: WHO: Health in 2015; Access to Medicine Index 2015
![Page 3: Eyeforpharma 2017](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58ed3f981a28ab1c768b460f/html5/thumbnails/3.jpg)
Sandoz International
The global population continues to grow, and the world is also getting older...
Rapid Aging
+500m
About 1.4 billion people worldwide are projected to be 60 or older by the year 2030, fueling a rise in chronic illness
60by 2030
over
![Page 4: Eyeforpharma 2017](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58ed3f981a28ab1c768b460f/html5/thumbnails/4.jpg)
Sandoz International
Increasing Healthcare Demand
... putting healthcare systems under increasing pressure...
13TIf growth trends continue, global healthcare outlays could rise to
USD 13 trillion by 2025
2025by
![Page 5: Eyeforpharma 2017](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58ed3f981a28ab1c768b460f/html5/thumbnails/5.jpg)
Sandoz International
![Page 6: Eyeforpharma 2017](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58ed3f981a28ab1c768b460f/html5/thumbnails/6.jpg)
Sandoz International
OPTION 2
![Page 7: Eyeforpharma 2017](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58ed3f981a28ab1c768b460f/html5/thumbnails/7.jpg)
Sandoz International
![Page 8: Eyeforpharma 2017](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58ed3f981a28ab1c768b460f/html5/thumbnails/8.jpg)
Sandoz International
![Page 9: Eyeforpharma 2017](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58ed3f981a28ab1c768b460f/html5/thumbnails/9.jpg)
Sandoz International
![Page 10: Eyeforpharma 2017](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58ed3f981a28ab1c768b460f/html5/thumbnails/10.jpg)
Sandoz International
![Page 11: Eyeforpharma 2017](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58ed3f981a28ab1c768b460f/html5/thumbnails/11.jpg)
Sandoz International
![Page 12: Eyeforpharma 2017](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58ed3f981a28ab1c768b460f/html5/thumbnails/12.jpg)
Thank you